← Back to Search

Imaging

CESM for Breast Cancer

N/A
Waitlist Available
Led By Jordana Phillips, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is testing whether using contrast-enhanced mammography can replace breast MRI for cancer screening.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diagnostic accuracy of CESM compared with breast MRI for breast cancer screening
Secondary outcome measures
Diagnostic accuracy of CESM compared with abbreviated MRI for breast cancer detection
Diagnostic accuracy of CESM compared with conventional mammography for breast cancer screening
Patient preference for breast MRI versus CESM for breast cancer screening

Trial Design

1Treatment groups
Experimental Treatment
Group I: CESM VS MRIExperimental Treatment2 Interventions
Each enrolled participant will receive both a CESM and MRI exam prior to the breast biopsy, if they had not been performed already as part of clinical care. MRI: Breast MRI will be performed, if not already performed as part of clinical care. CESM: After the MRI is complete, patients will be brought to the mammography department for the contrast enhanced mammogram. The CESM will only occur if not already performed as part of the patient's clinical care. Biopsy: Patients will then have their biopsy. Any additional findings seen on the CESM or MRI will be worked up also. Reader Study: The CESM and the MRI images will be included in a case set that is ready by 10 study radiologists at a later date, after the biopsy is performed. These radiologists will look at the images to see if CESM and MRI find the same number of breast cancers.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MRI
2009
Completed Phase 2
~1370

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
836 Previous Clinical Trials
13,010,148 Total Patients Enrolled
47 Trials studying Breast Cancer
7,183 Patients Enrolled for Breast Cancer
Dana-Farber Cancer InstituteOTHER
1,079 Previous Clinical Trials
340,866 Total Patients Enrolled
141 Trials studying Breast Cancer
22,535 Patients Enrolled for Breast Cancer
GE HealthcareIndustry Sponsor
290 Previous Clinical Trials
630,989 Total Patients Enrolled
32 Trials studying Breast Cancer
18,655 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
Vandana Dialani 2018. "Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03482557.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top